BIOSPECIFICS TECHNOLOGIES CORP·4

Aug 15, 9:02 PM ET

Wegman Thomas 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 15, 2018

Insider Transaction Report

Form 4
Period: 2018-08-14
Wegman Thomas
DirectorPresident10% Owner
Transactions
  • Sale

    Common Stock, $0.001 par value

    2018-08-14$51.21/sh15,987$818,646320,340 total
  • Sale

    Common Stock, $0.001 par value

    2018-08-15$50.00/sh7,921$396,056312,419 total
Footnotes (2)
  • [F1]Represents the weighted average sale price for total shares sold by the reporting person, including a range of prices from $50.00 to $54.11, inclusive.
  • [F2]Represents the weighted average sale price for total shares sold by the reporting person, including a range of prices from $50.00 to $50.002, inclusive.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES